Md Shamsuzzaman

Dr. Md Shamsuzzaman

Microbiology, Kyungpook National University, School of Medicine, Daegu, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
Ram Hari DahalRam Hari Dahal
Ram Hari Dahal
SKShukho Kim
Shukho Kim
JKJung Min Kim
Jung Min Kim
Three bacterial strains, B5-R-101T, TA-R-1T, and BL-R-1T, were isolated from the feces of a healthy Korean individual. Cells of these strains were Gram-stain-positive, facultatively anaerobic, oxidase-negative, catalase-positive, rod-shaped, and non-motile. They were able to grow within a temperature range of 10–42°C (optimum, 32–37°C), at a pH range of 2.0–10.0 (optimum, pH 5.5–8.0), and at NaCl concentration of 0.5–10.5% (w/v). All the three strains exhibited 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities ranging from 58 ± 1.62 to 79 ± 1.46% (% inhibition). These strains survived in lower pH (2.0) and in 0.3% bile salt concentration for 4 h. They did not show hemolytic activity and exhibited antimicrobial activity against pathogenic bacteria, such as Escherichia coli, Acinetobacter baumannii, Staphylococcus aureus, and Salmonella enterica. The genomic analysis presented no significant concerns regarding antibiotic resistance or virulence gene content, indicating these strains could be potential probiotic candidates. Phylogenetic analysis showed that they belonged to the genus Corynebacterium, with 98.5–99.0% 16S rRNA gene sequence similarities to other members of the genus. Their major polar lipids were diphosphatidylglycerol and phosphatidylglycerol. The abundant cellular fatty acids were C16:0, C18:1ω9c, and anteiso-C19:0. Genomic analysis of these isolates revealed the presence of genes necessary for their survival and growth in the gut environment, such as multi-subunit ATPases, stress response genes, extracellular polymeric substance biosynthesis genes, and antibacterial genes. Furthermore, the genome of each strain possessed biosynthetic gene clusters with antioxidant and antimicrobial potentials, including terpenes, saccharides, polyketides, post-translationally modified peptides (RIPPs), and non-ribosomal peptides (NRPs). In silico DNA–DNA hybridization (dDDH) and average nucleotide identity (ANI) values were lower than the thresholds to distinguish novel species. Based on phenotypic, genomic, phylogenomic, and phylogenetic analysis, these potential probiotic strains represent novel species within the genus Corynebacterium, for which the names Corynebacterium intestinale sp. nov. (type strain B5-R-101T = CGMCC 1.19408T = KCTC 49761T), Corynebacterium stercoris sp. nov. (type strain TA-R-1T = CGMCC 1.60014T = KCTC 49742T), and Corynebacterium faecium sp. nov. (type strain BL-R-1T = KCTC 49735T = TBRC 17331T) are proposed.

12 December 2024 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
SKShukho Kim
Shukho Kim
JKJung Min Kim
Jung Min Kim
The emergence of the multidrug-resistant (MDR) Escherichia coli ST131 clone has significantly impacted public health. With traditional antibiotics becoming less effective against MDR bacteria, there is an urgent need for alternative treatment options. This study aimed to isolate and characterize four lytic phages (EC.W2-1, EC.W2-6, EC.W13-3, and EC.W14-3) from hospital sewage water and determine their effectiveness against the ST131 clone. These phages demonstrated a broad host range, effectively lysing 94.4% of highly pathogenic E. coli ST131 isolates. Morphological observations and phylogenetic analysis indicate that EC.W2-1, and EC.W13-3 belong to the Tequatrovirus genus in the Straboviridae family, while EC.W2-6 and EC.W14-3 are part of the Kuravirus genus in the Podoviridae family. Phages remained stable at pH 2–10 for 4 h and below 80°C for 1 h. These four phages showed in vitro bacterial lytic activity at various MOIs (0.1–0.001). The one-step growth curve of phages exhibited a short latent period of approximately 10–20 min and a moderate burst size of 50–80 (pfu/cell). Phages’ genome size ranged from 46,325–113,909 bp, with G + C content of 35.1 –38.3%. No virulence or drug resistance genes were found, which enhanced their safety profile. In vivo, EC.W2-6 and EC.W13.3, along with their cocktail, fully protected against the ESBL-producing E. coli ST131 infection model in vivo. Combining these phages and a 3-day repeated single phage, EC.W13-3 significantly enhanced the survival rate of E. coli ST131 infected mice at low MOI (0.01–0.001). The in vivo effectiveness of the isolated phages and the EC.W2-6 and EC.W14-3 cocktail in highly reducing bacterial load CFU/g in multiple organs strongly supports their potential efficacy. Based on in vivo, in vitro, and genomic analyses, phages have been proposed as novel and suitable candidates for killing the pandemic ST131 clone.

29 October 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
KKKathirvel Kalaiselvi
Kathirvel Kalaiselvi
Mayakrishnan PrabakaranMayakrishnan Prabakaran
Mayakrishnan Prabakaran
Mangroves are plants known for their various medicinal and economical values, and therefore are widely investigated for their phytochemical, antioxidant, antidiarrheal, and antimicrobial activities. In the present study, we analyze the antioxidant and anticorrosive properties of Ceriops tagal (C. tagal), a tropical and subtropical mangrove plant of the Rhizophoraceae family. The total phenolic content (TPC) and total flavonoid content (TFC) were found to be 101.52 and 35.71 mg/g, respectively. The extract (100 µg/mL) exhibited 83.88, 85, and 87% antioxidant property against 1,1-diphenyl-2-picrylhydrazyl (DPPH), nitric oxide, and hydrogen peroxide free radicals. In addition, 600 ppm of C. tagal extract showed 95% corrosion inhibition against 1 M HCl attack on mild steel at 303 ± 1 K, which declined over other concentrations and temperatures, where AAS produced 82% inhibition at 600 ppm. UV-visible spectroscopy analysis revealed the formation of an inhibitor metal complex. The elemental analysis provided the presence of 84.21, 9.01, and 6.37% of Fe, O, and C, respectively, in inhibited mild steel, whereas the same were 71.54, 22.1, and 4.34%, respectively, in uninhibited specimen, stressing the presence of protective film on the metal surface. Scanning electron microscopy (SEM) also showed some noteworthy changes in both uninhibited and inhibited mild steel, making C. tagal plant a better alternative than any other synthetic inhibitors. Further, the atomic force microscopy (AFM) surface topography analysis showed that 600 ppm of C. tagal extract significantly diminished corrosion on the surface of mild steel.

21 April 2025 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
SKShukho Kim
Shukho Kim
JKJung Min Kim
Jung Min Kim
The emergence of extended-spectrum β-lactamase (ESBL)-producing E. coli and carbapenem-resistant E. coli (CREC) is a significant global health challenge. This study focuses on isolating and characterizing two novel phages, EC.W1-9 and EC.W15-4, and investigating their efficacy with antibiotics against these resistant E. coli. In vivo experiments were conducted using BALB/c mice, and E.coli isolates were collected, cultured, and evaluated for antibiotic susceptibility. Phages were isolated from hospital sewage and prepared to infect the E. coli. The isolated phages, EC.W1-9 and EC.W15-4, belonged to the Podoviridae and Straboviridae families, and lack integrase or toxin-coding genes, indicating safety for therapeutic use. The combination of these phages significently enhanced their lytic ability, lysing 61.7% of 60 E. coli isolates, compared to 41.6%-55% lysis by individual phages. Furthermore, the phage combination demonstrated 100% susceptibility against different E. coli sequence types, including ST73, ST648, ST2311, ST405, ST7962, ST131, ST13003, and ST167. Additionally, synergy between antibiotics and phage combinations improved susceptibility rates to 73.3% for ESBL producers and 54% for CREC. The combined treatment of isolated phages and antibiotics significantly increased survival rates in BALB/c mice exposed to resistant STs of E.coli, including ST131, ST648, and ST410. Survival rates against ST131 increased by approximately 75% and 50% compared to treatment individual phages. Combined treatment with two phages and antibiotics resulted in 75-100% survival against E. coli ST410 and 100% survival against ST648 CONCLUSIONS: This study highlights the therapeutic importance of phage and phage-antibiotic combinations in combating ESBL-producing E. coli and CREC isolates.

7 November 2024 in Foodborne Pathogens and Disease
Verified
Journal Article
Closed access
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
SKShukho Kim
Shukho Kim
YCYoon-Jung Choi
Yoon-Jung Choi
BKBokyung Kim
Bokyung Kim
RDRam Hari Dahal
Ram Hari Dahal
JKJungmin Kim
Jungmin Kim
Carbapenem-resistant Escherichia coli (CREC) is a global threat to public health; therefore, alternative treatment options are urgently needed. Bacteriophages have emerged as promising candidates for combating CREC infections. This study aimed to investigate the genetic basis of phage sensitivity in CREC by evaluating carbapenem resistance among multidrug-resistant (MDR) E. coli isolated in Daegu, South Korea and analyzing their sequence types (STs) with phage susceptibility spectra. Among the 60 MDR E. coli isolates, 80.4% were identified as CREC, with 77.0% demonstrating resistance to imipenem and 66.6% to meropenem. Moreover, 70 lytic E. coli bacteriophages were isolated from hospital sewage water and evaluated against those 60 E. coli isolates. The phages exhibited lytic activity of 33%–60%, with average titers ranging from 5.6 × 10 12 to 2.4 × 10 13 PFU/mL (Plaque-Forming Unit). Furthermore, multilocus sequence typing (MLST) analysis of the bacterial isolates revealed 14 distinct STs, mostly belonging to ST131, ST410, and ST648. Notably, the phage susceptibility spectra of ST73, ST13003, ST648, ST2311, ST167, ST405, ST607, ST7962, and ST131 were significantly different. Thus, the isolated phages can effectively lyse CREC isolates, particularly those with clinically dominant STs. Conversely, ST410 exhibited a 14.2%–87.14% susceptibility spectrum, whereas ST1139, ST1487, ST10, and ST206 did not lyse, suggesting the presence of more resistant STs. Future studies are warranted to identify the reasons behind this resistance and address it. Ultimately, this study will aid in developing focused treatments to address these pressing global health issues.

7 October 2025 in Microbiology Spectrum
Verified
Journal Article
Open access
YCYoon-Jung Choi
Yoon-Jung Choi
Md ShamsuzzamanMd Shamsuzzaman
Md Shamsuzzaman
CPChaewon Park
Chaewon Park
SKShukho Kim
Shukho Kim
MSMinsang Shin
Minsang Shin
JKJung Min Kim
Jung Min Kim
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major public health threat due to high mortality and limited treatment options. Bacteriophage (phage) therapy offers a promising alternative, but its long-term efficacy is challenged by the rapid emergence of phage-resistant bacterial populations. This study evaluates phage vB_AbaSt_W16 and whether sequential phage-antibiotic therapy enhances bacterial clearance and suppresses resistance. The optimal multiplicity of infection (MOI) for vB_AbaSt_W16 was determined across various CRAB strains. PAS was assessed in vitro using meropenem, colistin, tigecycline, rifampin, and ampicillin/sulbactam. An immunocompromised BALB/c mouse model was used to evaluate the therapeutic efficacy of phage monotherapy and combination therapy. Antibiotics were administered either concurrently with phage or sequentially 6 h after phage treatment. Bacterial clearance, survival rates, and the emergence of phage-resistant populations were monitored. Phage monotherapy inhibited bacterial growth at MOIs of 0.1–10, but high-dose treatment (MOI > 100) caused rapid regrowth within 12 h due to resistance emergence. Phage-antibiotic synergy (PAS) was observed only with tigecycline (FICI = 0.225), though the effect was transient. In the mouse model, phage monotherapy at MOIs of 0.1–1 achieved 100% survival, whereas MOI 10 reduced survival to 40%, correlating with increased bacterial burden and resistance emergence. Notably, sequential administration of colistin 6 h post-phage treatment improved survival to 100%, while colistin monotherapy resulted in survival below 40%. Sequential colistin treatment also effectively suppressed resistant bacterial populations, reducing them to nearly undetectable levels by day 4. High-dose phage treatment was limited by rapid resistance development. In contrast, sequential phage-antibiotic therapy, particularly when combined with colistin, significantly improved bacterial clearance, enhanced survival outcomes, and suppressed resistance emergence. These findings support sequential phage-antibiotic therapy as a strategy for CRAB infections. IMPORTANCE: The rise of carbapenem-resistant Acinetobacter baumannii (CRAB) presents a severe challenge in healthcare settings, where treatment options are increasingly limited. While bacteriophage therapy offers a novel antimicrobial approach, its effectiveness is often hindered by the rapid emergence of phage-resistant bacterial populations. This study demonstrates that sequential phage-antibiotic therapy, particularly phage followed by colistin, significantly improves survival rates and suppresses resistance emergence in a murine infection model. Unlike monotherapies, this strategy optimally combines the bacterial-killing mechanisms of phages and antibiotics, offering a clinically viable solution to combat multidrug-resistant infections. Our findings provide valuable translational insights, supporting the potential application of phage therapy in human medicine. By addressing the critical issue of phage resistance, this study advances the development of sustainable bacteriophage-antibiotic treatment regimens against CRAB and other drug-resistant pathogens.